First Time Loading...

Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 229.03 USD 0.54% Market Closed
Updated: Apr 28, 2024
Section:
 

Relative Value

The Relative Value of one CRL stock under the Base Case scenario is 356.99 USD. Compared to the current market price of 229.03 USD, Charles River Laboratories International Inc is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CRL Relative Value
Base Case
356.99 USD
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
61
vs Industry
59
Median 3Y
3.2
Median 5Y
3
Industry
3.9
Forward
2.8
More Details
24.8
P/E
P/E
Price to Earnings
24.8
vs History
73
vs Industry
29
Median 3Y
26.4
Median 5Y
29.3
Industry
30.3
Forward
20.5
More Details
17.2
P/OCF
P/OCF
Price to OCF
17.2
vs History
57
vs Industry
34
Median 3Y
18.3
Median 5Y
17.4
Industry
23.2
More Details
65
P/FCFE
P/FCFE
Price to FCFE
65
vs History
4
vs Industry
11
Median 3Y
22.6
Median 5Y
16.4
Industry
26.9
More Details
3.3
P/B
P/B
Price to Book Value
3.3
vs History
88
vs Industry
30
Median 3Y
4.2
Median 5Y
4.6
Industry
2.5
More Details
3.4
EV/S
EV/S
Enterprise Value to Sales
3.4
vs History
71
vs Industry
47
Median 3Y
3.8
Median 5Y
3.7
Industry
3.8
Forward
3.3
More Details
9.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.2
vs History
73
vs Industry
38
Median 3Y
10.3
Median 5Y
10
Industry
7.7
More Details
14.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.5
vs History
66
vs Industry
34
Median 3Y
15.4
Median 5Y
15.8
Industry
16.8
Forward
12.8
More Details
21.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.4
vs History
68
vs Industry
29
Median 3Y
22.1
Median 5Y
23.6
Industry
22
Forward
16.3
More Details
20.7
EV/OCF
EV/OCF
Enterprise Value to OCF
20.7
vs History
63
vs Industry
32
Median 3Y
22.1
Median 5Y
21.2
Industry
21.1
More Details
38.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
38.7
vs History
44
vs Industry
18
Median 3Y
44
Median 5Y
37.3
Industry
27.6
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
80
vs Industry
49
Median 3Y
2.1
Median 5Y
2.1
Industry
2.4
More Details

Multiples Across Competitors

CRL Competitors Multiples
Charles River Laboratories International Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Charles River Laboratories International Inc
NYSE:CRL
11.8B USD 2.8 24.8 14.5 21.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.8B USD 5.2 37 22.8 33.5
US
Danaher Corp
NYSE:DHR
182.6B USD 4.2 22.6 16.5 20.3
US
IQVIA Holdings Inc
NYSE:IQV
42.6B USD 2.8 31.4 17 26.2
CH
Lonza Group AG
SIX:LONN
38.1B CHF 5.7 58.2 20 29.3
US
Agilent Technologies Inc
NYSE:A
40.4B USD 6 32.7 26.1 31.4
KR
Samsung Biologics Co Ltd
KRX:207940
54.8T KRW 14.8 63.9 33.7 48.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.7B USD 7 33.8 23.6 26.3
US
West Pharmaceutical Services Inc
NYSE:WST
26.5B USD 9 44.6 30.5 36.5
IE
ICON PLC
NASDAQ:ICLR
25.4B USD 3.1 41.5 17.6 27.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
CRL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRL stock valuation using valuation multiples.
Wall Street Estimates
CRL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.